ArticleCureus2026
Aquagenic Wrinkling of the Palms as a Screening Indicator for Cystic Fibrosis Beyond Infancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aquagenic wrinkling of the palms (AWP) has been associated with cystic fibrosis (CF) and may support screening approaches beyond infancy in low-resource settings. We evaluated the diagnostic accuracy and reproducibility of a standardized brief immersion in water (BIW) test in 100 children with genetically confirmed CF, 50 heterozygous CF transmembrane conductance regulator (CFTR) mutation carriers, and 100 age-matched healthy controls. Both hands were immersed in tap water (22-24°C) for 11 minutes and assessed at 3, 7, and 11 minutes. Transepidermal water loss (TEWL) was measured after immersion using a portable VapoMeter. Early AWP at three minutes occurred in 68/100 (68%) CF patients, 4/50 (8%) CFTR heterozygous carriers, and 0/100 (0%) controls (p < 0.01); at the three-year follow-up, 35/50 (70%) CF patients again showed early wrinkling. Wrinkling with papule formation at seven minutes provided optimal discrimination (94% sensitivity, 98.3% specificity). A TEWL threshold ≥ 203 g/m²/h further differentiated CF from non-CF participants (86% sensitivity, 98% specificity). The BIW test is rapid, reproducible, and feasible in resource-limited settings; thus, a positive seven-minute response should prompt confirmatory testing (e.g., sweat chloride and/or CFTR genotyping).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.